Looming "patent cliff" drives a surge in drugmaker M&A

11/14/2010 | Philadelphia Inquirer, The

A recent wave of mergers and acquisitions in the drug industry was largely driven by impending revenue loss from a "patent cliff," experts said. "Over the next five years, the pharmaceutical industry will face the sharpest revenue decline in history," according to a December report by Bernstein Research. "Of the top 10 biggest drugs in the world, nine will lose patent protection; of the top 20, 18 will lose protection."

View Full Article in:

Philadelphia Inquirer, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Accreditation
Meridian Health Plan
Detroit, MI
Stop Loss Sales Executive, (Southern Region)
Indigo Insurance Services
Multiple Locations, SL_Multiple Locations
Chief Executive Officer
Center for Improving Value in Healthcare
Denver, CO
Quality Program Manager II, State Programs
Tufts Health Plan
Watertown, MA
Senior director risk adjustor and coding doc
Novant Health
Charlotte, NC